Reactions Weekly

, Volume 1739, Issue 1, pp 35–35 | Cite as


Angioedema: 7 case reports
Case report
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

In a retrospective study, 7 patients (four women and three men) aged 44−77 years were described, who developed angioedema during treatment with olmesartan medoxomil, irbesartan, candesartan cilexetil, valsartan, telmisartan, fimasartan, eprosartan or lisinopril for hypertension [routes and frequencies not stated].

Case 1: A 77-year-old woman developed angioedema during treatment with olmesartan medoxomil, irbesartan and candesartan cilexetil for hypertension. The woman, who had a history of allergic rhinitis, had been receiving prednisolone for more than 12 months for multifocal pneumonia and rheumatic diseases. Additionally, she had been receiving losartan for high BP for the past several years and she had no particular symptoms. Subsequently, losartan was switched to...


  1. Kim H, et al. Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea. Basic and Clinical Pharmacology and Toxicology 124: 115-122, No. 1, Jan 2019. Available from: URL: - South KoreaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations